180
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design

, , , , , , , , , , & show all
Pages 5529-5542 | Published online: 01 Sep 2015

References

  • MylerPJFaselNLeishmania After the GenomeSeattleCaister Academic Press2008
  • World Health OrganizationControl of Leishmaniases. ReportGenevaWorld Health Organization2010WHO Technical Report Series, 949
  • KimDHChungHJBleysJGhohestaniRFIs paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trialsPLoS Negl Trop Dis200932e38119221595
  • Ben SalahAZakraouiHZaatourAA randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointmentAm J Trop Med Hyg19955321621667677218
  • Ben SalahABen MessaoudNGuedriETopical paromomycin with or without gentamicin for cutaneous leishmaniasisN Engl J Med2013368652453223388004
  • LarbiEBAlkhawajahAAlgindanYJainSAbahusainAAlzayerAA randomized, double-blind, clinical-trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the Eastern Province of Saudi-ArabiaAm J Trop Med Hyg19955221661687872446
  • SinghSSivakumarRChallenges and new discoveries in the treatment of leishmaniasisJ Infect Chemother200410630731515614453
  • StorerEWayteJCutaneous leishmaniasis in Afghani refugeesAustralas J Dermatol2005462808315842398
  • SeebergerJDaoudSPammerJTransient effect of topical treatment of cutaneous leishmaniasis with imiquimodInt J Dermatol200342757657912839616
  • SampaioRNRLucasICTakamiHLInefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensisJ Venom Anim Toxins Incl Trop Dis2007133598606
  • Monge-MailloBLópez-VélezRTherapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasisDrugs201373171889192024170665
  • BoeckPFalcãoCABLealPCSynthesis of chalcone analogues with increased antileishmanial activityBioorg Med Chem20061451538154516386424
  • YunesRChiaradiaLDLealPCChalcones as new drug leads against leishmaniasisRichardsRCurrent Trends in Medicinal ChemistryTrivandrumResearch Trends20064756
  • NowakowskaZA review of anti-infective and anti-inflammatory chalconesEur J Med Chem200742212513717112640
  • Andrighetti-FrohnerCROliveiraKNSilvaDGSynthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivates with potential antileishmanial activityEur J Med Chem200944275576318554753
  • Rossi-BergmannBFalcãoCABZanchettaBBentleyMVLBSantanaMHAPerformance of elastic liposomes for topical treatment of cutaneous leishmaniasisBeckRGuterresSPohlmannANanocosmetics and Nanomedicines: New Approaches for Skin CareGermanySpringer2011181196
  • TadrosTIzquierdoPEsquenaJSolansCFormation and stability of nano-emulsionsAdv Colloid Interface Sci2004108–109303318
  • KhuranaSJainPNKBediMSNanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigationLife Sci2013926–738339223353874
  • BaroliBPenetration of nanoparticles and nanomaterials in the skin: fiction or reality?J Pharm Sci2010991215019670463
  • KelmannRGKuminekGTeixeiraHFKoesterLSCarbamazepine parenteral nanoemulsions prepared by spontaneous emulsification processInt J Pharm20073421–223123917582711
  • ToniniMLDesenvolvimento de um Teste Colorimétrico Para Triagem da Atividade Leishmanicida de Compostos Utilizando Leishmania amazonensis Expressando a Enzima Beta-Galactosidase [dissertation]FlorianópolisUniversity Federal of Santa Catarina2013
  • TsuchiyaSYamabeMYamaguchiYKobayashiYKonnoTTadaKEstablishment and characterization of a human acute monocytic leukemia cell line (THP-1)Int J Cancer19802621711766970727
  • FumarolaLSpinelliRBrandonisioOIn vitro assays for evaluation of drug activity against Leishmania sppRes Microbiol2004155422423015142618
  • van de LoosdrechtAANennieEOssenkoppeleGJBeelenRHLangenhuijsenMMCell mediated cytotoxicity against V937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological studyJ Immunol Methods1991141115221865120
  • SieuwertsAMKlijnJGPetersHAFoekensJAThe MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell culture in vitro for the assessment of growth characteristics, IC50-values and cell survivalEur J Clin Chem Clin Biochem199533118138238620058
  • GarciaIPouzetCBrulasMBouzaEBottoJMDomlogeNEvaluation of THP-1 cell line as an in vitro model for long-term safety assessment of moleculesInt J Cosmet Sci201335656857423841697
  • BenitaSSubmicron Emulsion in Drug Targeting and DeliveryAmsterdamHarwood Academic Publishers1998
  • WangLTaborREastoeJLiXHeenanRKDongJFormation and stability of nanoemulsions with mixed ionic–nonionic surfactantsPhys Chem Chem Phys200911429772977819851556
  • FiumeZFinal report on the safety assessment of lecithin and hydrogenated lecithinInt J Toxicol200120Suppl 1214511358109
  • BenitaSLevyMYSubmicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterizationJ Pharm Sci19938211106910798289116
  • SaberiAHFangYMcclementsDJFabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsificationJ Colloid Interface Sci20133919510223116862
  • WangLDongJChenJEastoeJLiXDesign and optimization of a new self-nanoemulsifying drug delivery systemJ Colloid Interface Sci2009330244344819038395
  • BaroliBEnnasMGLoffredoFIsolaMPinnaRLópez-QuintelaMAPenetration of metallic nanoparticles in human full-thickness skinJ Invest Dermatol200712771701171217380118
  • BabootaSShakeelFAhujaAAliJShafiqSDesign development and evaluation of novel nanoemulsions formulations for transdermal potential of celecoxibActa Pharm200757331533217878111
  • LiuWSunDLiCLiuQXuJFormation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point methodJ Colloid Interface Sci2006303255756316905141
  • FronzaTCamposATeixeiraHNanoemulsões como sistemas de liberação para fármacos oftálmicosActa Farm Bonaerense2004234558556
  • JummaMMullerBWPhysicochemical properties of chitosan-lipid emulsions and their stability of parenteral fat emulsionsInt J Pharm19981638189
  • SilvanderMHellstromAWarnheimTClaessonPRheological properties of phospholipid-stabilized parenteral oil-in-water emulsions – effects of electrolyte concentration and presence of heparinInt J Pharm20032521–212313212550787
  • PalRA novel method to correlate emulsion viscosity dataColloids Surf A Physicochem Eng Asp19981371–3275286
  • SznitowskaMJanickiSBaczekAStudies on the effect of pH on the lipoidal route of penetration across stratum corneumJ Control Release200176332733511578746
  • Cazares-DelgadilloJNaikAKaliaYNQuintanar-GuerreroDGanem-QuintanarASkin permeation enhancement by sucrose esters: a pH-dependent phenomenonInt J Pharm20052971–220421215878811
  • HoellerSSpergerAValentaCLecithin based nanoemulsions: a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeationInt J Pharm20093701–218118619073240
  • KirjavainenMMönkkönenJSaukkosaariMValjakka-KoskelaRKiesvaaraJUrttiAJPhospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayersJ Control Release199958220721410053193
  • SantosCMOliveiraRBArantesVTAmphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studiesJ Biomed Nanotechnol20128232232922515084
  • LopezALlinaresFCortellCHerraezMComparative enhancer effects of Span®20 with Tween®20 and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicitiesInt J Pharm20002021–213314010915936
  • FangJYYuSYWuPCHuangYBTsaiYHIn vitro skin permeation of estradiol from various proniosome formulationsInt J Pharm20012151–2919911250095
  • ThongHYZhaiHMaibachHIPercutaneous penetration enhancers: an overviewSkin Pharmacol Physiol200720627228217717423
  • NokhodchiAShokriJDashbolaghiAHassan-ZadehDGhafourianTBarzegar-JalaliMThe enhancement effect of surfactants on the penetration of lorazepam through rat skinInt J Pharm2003250235936912527163
  • SomIBhatiaKYasirMStatus of surfactants as penetration enhancers in transdermal drug deliveryJ Pharm Bioallied Sci2012412922368393
  • AkhtarNRehmanMUKhanHMSRasoolFSaeedTMurtazaGPenetration enhancing effect of polysorbate 20 and 80 on the in vitro percutaneous absorption of L-ascorbic acidTrop J Pharm Res2011103281288
  • IdreesMARahmanNUAhmadSAliMYAhmadIEnhance trans-dermal delivery of flurbiprofen via microemulsions: effects of different types of surfactants and cosurfactantsDaru201119643343923008689
  • TeeranachaideekulVBoonmePSoutoEBMüllerRHJunyaprasertVBInfluence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLCJ Control Release2008128213414118423768
  • GroglMHickmanMEllisWReview: drug discovery algorithm for cutaneous leishmaniasisAm J Trop Med Hyg201388221622123390221
  • PoorrajabFArdestaniSKForoumadiASelective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania speciesExp Parasitol2009121432333019124020
  • Ramirez-MaciasIMaldonadoCRMarinCIn vitro antileishmania evaluation of nickel complexes with a triazolopyrimidine derivative against Leishmania infantum and Leishmania braziliensisJ Inorg Biochem20121121922542591
  • RodriguesKAFAmorimLVDiasCNMoraesDFCCarneiroSMPCarvalhoFAASyzygium cumini (L.) Skeels essential oil and its major constituent α-pinene exhibit anti-leishmania activity through immunomodulation in vitroJ Ethnopharmacol2015160324025460590
  • TiwariAKumarSSuryawanshiSNMittalMVishwakarmaPGuptaSChemotherapy of leishmaniasis part X: synthesis and bioevaluation of novel terpenyl heterocyclesBioorg Med Chem Lett201323124825123177254
  • DagninoAPBarrosFMCCcan-CcapatintaGVProphiroJSVon PoserGLRomãoPRTLeishmanicidal activity of lipophilic extracts of some Hypericum speciesPhytomedicine2015221717625636874
  • SchwartzJMorenoEFernándezCTopical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulationEur J Pharm Sci20146230931624964292
  • BrothertonMCBourassaSLégaréDPoirierGGDroitAOuelletteMQuantitative proteomic analysis of amphotericin B resistance in Leishmania infantumInt J Parasitol Drugs Drug Resist2014412613225057462
  • KaurGRajputBComparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in LeishmaniaJ Parasitol Res2014201472632810.1155/2014/72632824900912